Pentomone (INN , USAN ) (developmental code name Lilly 113935 or LY-113935) is a nonsteroidal antiandrogen (NSAA) described as a "prostate growth inhibitor" which was never marketed.[1] It was synthesized and assayed in 1978.[1]
Clinical data | |
---|---|
Other names | Lilly 113935; LY-113935 |
Drug class | Nonsteroidal antiandrogen |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C24H26O5 |
Molar mass | 394.467 g·mol−1 |
3D model (JSmol) |
|
| |
|